NCT03086785 2018-01-17Prospective, Multicenter, Observational Study of Apatinib Single or Combined Capecitabine for Treatment of Patients With Metastatic Her-2 Negative Breast CancerHebei Medical University Fourth HospitalPhase 2 Unknown120 enrolled